Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia

Hideaki Katagiri,1 Masanori Taketsuna,2 Shinpei Kondo,3 Kenta Kajimoto,4 Etsuko Aoi,5 Yuka Tanji1 1Bio-Medicines, Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan; 2Statistical Sciences, Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan; 3Post Marketing Study Ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Katagiri H, Taketsuna M, Kondo S, Kajimoto K, Aoi E, Tanji Y
Format: article
Language:EN
Published: Dove Medical Press 2018
Subjects:
agitation
oral
postmarketing surveillance study
rapid-acting intramuscular olanzapine
schizophrenia
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Online Access:https://doaj.org/article/2e48f8bb99f147df94bc5b0b241a6263
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/2e48f8bb99f147df94bc5b0b241a6263

Similar Items